Mirae Asset Global Investments’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.12K | Buy |
3,234
+512
| +19% | +$1.13K | ﹤0.01% | 1525 |
|
2025
Q1 | $3.4K | Sell |
2,722
-29
| -1% | -$36 | ﹤0.01% | 1525 |
|
2024
Q4 | $3.33K | Sell |
2,751
-232
| -8% | -$281 | ﹤0.01% | 1572 |
|
2024
Q3 | $10.4K | Buy |
2,983
+528
| +22% | +$1.84K | ﹤0.01% | 1495 |
|
2024
Q2 | $11.6K | Sell |
2,455
-312,319
| -99% | -$1.48M | ﹤0.01% | 1450 |
|
2024
Q1 | $2.25M | Buy |
314,774
+116,803
| +59% | +$834K | ﹤0.01% | 1144 |
|
2023
Q4 | $2.01M | Sell |
197,971
-177,556
| -47% | -$1.8M | ﹤0.01% | 1256 |
|
2023
Q3 | $2.93M | Buy |
375,527
+26,230
| +8% | +$205K | 0.01% | 1026 |
|
2023
Q2 | $2.87M | Buy |
349,297
+31,420
| +10% | +$258K | 0.01% | 1053 |
|
2023
Q1 | $2.3M | Buy |
317,877
+28,275
| +10% | +$205K | 0.01% | 1152 |
|
2022
Q4 | $2.57M | Sell |
289,602
-63,137
| -18% | -$560K | 0.01% | 1039 |
|
2022
Q3 | $4.32M | Buy |
352,739
+46,080
| +15% | +$564K | 0.01% | 858 |
|
2022
Q2 | $3.63M | Buy |
306,659
+89,458
| +41% | +$1.06M | 0.01% | 937 |
|
2022
Q1 | $4.13M | Sell |
217,201
-43,810
| -17% | -$833K | 0.01% | 939 |
|
2021
Q4 | $6.93M | Buy |
261,011
+55,940
| +27% | +$1.49M | 0.01% | 792 |
|
2021
Q3 | $8.42M | Buy |
205,071
+38,454
| +23% | +$1.58M | 0.02% | 703 |
|
2021
Q2 | $9.44M | Buy |
166,617
+28,041
| +20% | +$1.59M | 0.03% | 655 |
|
2021
Q1 | $5.82M | Buy |
138,576
+62,711
| +83% | +$2.63M | 0.02% | 703 |
|
2020
Q4 | $5.32M | Buy |
75,865
+25,173
| +50% | +$1.76M | 0.02% | 638 |
|
2020
Q3 | $1.42M | Buy |
50,692
+15,921
| +46% | +$447K | 0.01% | 869 |
|
2020
Q2 | $1.03M | Buy |
34,771
+14,926
| +75% | +$441K | 0.01% | 896 |
|
2020
Q1 | $393K | Buy |
19,845
+2,166
| +12% | +$42.9K | ﹤0.01% | 1101 |
|
2019
Q4 | $524K | Buy |
17,679
+2,419
| +16% | +$71.7K | ﹤0.01% | 1203 |
|
2019
Q3 | $347K | Buy |
+15,260
| New | +$347K | ﹤0.01% | 1274 |
|